{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:44:12Z","timestamp":1775724252220,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374099"],"award-info":[{"award-number":["82374099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272532"],"award-info":[{"award-number":["82272532"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LBY21H060002"],"award-info":[{"award-number":["LBY21H060002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.intimp.2025.114817","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T11:36:44Z","timestamp":1746877004000},"page":"114817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Monotropein synergizes with methotrexate to attenuate synovial inflammation in adjuvant-induced arthritis mice and fibroblast-like synoviocyte via GSK-3\u03b2"],"prefix":"10.1016","volume":"158","author":[{"given":"Yi","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Hua","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Ru","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Yuan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Man","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Wen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan-Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Ping","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao-Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10416","key":"10.1016\/j.intimp.2025.114817_bb0005","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2025.114817_bb0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1742-1241.1994.tb09763.x","article-title":"Disease-modifying antirheumatic drugs in rheumatoid arthritis: current concepts","volume":"48","author":"Emery","year":"1994","journal-title":"Br. J. Clin. Pract."},{"issue":"4","key":"10.1016\/j.intimp.2025.114817_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040880","article-title":"Update on the Pathomechanism, diagnosis, and treatment options for rheumatoid arthritis","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.intimp.2025.114817_bb0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41584-022-00883-4","article-title":"Busting the myth of methotrexate chronic hepatotoxicity","volume":"19","author":"Di Martino","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7","key":"10.1016\/j.intimp.2025.114817_bb0025","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/annrheumdis-2020-219214","article-title":"Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial","volume":"80","author":"Combe","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2025.114817_bb0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41401-021-00654-z","article-title":"TNF-alpha impairs EP4 signaling through the association of TRAF2-GRK2 in primary fibroblast-like synoviocytes","volume":"43","author":"Tai","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.intimp.2025.114817_bb0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13075-018-1607-y","article-title":"From supernatants to cytokines: a personal view on the early history of IL-1, IL-1Ra, TNF and its inhibitor in rheumatology","volume":"20","author":"Dayer","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.intimp.2025.114817_bb0040","doi-asserted-by":"crossref","first-page":"ii64","DOI":"10.1093\/rheumatology\/kew347","article-title":"Stable activation of fibroblasts in rheumatic arthritis-causes and consequences","volume":"55","author":"Korb-Pap","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.intimp.2025.114817_bb0045","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/acr2.11093","article-title":"Joint location-specific JAK-STAT signaling in rheumatoid arthritis fibroblast-like Synoviocytes","volume":"1","author":"Hammaker","year":"2019","journal-title":"ACR Open Rheumatol"},{"issue":"2","key":"10.1016\/j.intimp.2025.114817_bb0050","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s10753-020-01371-1","article-title":"Destructive roles of fibroblast-like Synoviocytes in chronic inflammation and joint damage in rheumatoid arthritis","volume":"44","author":"Masoumi","year":"2021","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.intimp.2025.114817_bb0055","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12906-020-02895-7","article-title":"Iridoid glycosides from Morinda officinalis how. Exert anti-inflammatory and anti-arthritic effects through inactivating MAPK and NF-kappaB signaling pathways","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.intimp.2025.114817_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118486","article-title":"Morinda officinalis iridoid glycosides alleviate methotrexate-induced liver injury in CIA rats by increasing liver autophagy and improving lipid metabolism homeostasis","volume":"333","author":"Zhu","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"19","key":"10.1016\/j.intimp.2025.114817_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/nu14193978","article-title":"Monotropein protects against inflammatory bone loss and suppresses osteoclast formation and bone resorption by inhibiting NFATc1 via NF-kappaB and Akt\/GSK-3beta pathway","volume":"14","author":"Zhang","year":"2022","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.intimp.2025.114817_bb0070","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1084\/jem.159.5.1388","article-title":"Pathogenetic difference between collagen arthritis and adjuvant arthritis","volume":"159","author":"Kaibara","year":"1984","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.114817_bb0075","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/abbs\/gmab027","article-title":"Complete Freund\u2019s adjuvant-induced decrement of pruriceptor-mediated suppression of itch","volume":"53","author":"Yin","year":"2021","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"issue":"9","key":"10.1016\/j.intimp.2025.114817_bb0080","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.114817_bb0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13075-019-1935-6","article-title":"A novel function of artesunate on inhibiting migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients","volume":"21","author":"Ma","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2025.114817_bb0090","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.apsb.2021.12.023","article-title":"Gentiopicroside targets PAQR3 to activate the PI3K\/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism","volume":"12","author":"Xiao","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2025.114817_bb0095","first-page":"70","article-title":"Addition in concomitant medication","volume":"1","author":"Jin","year":"1980","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2025.114817_bb0100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bcp.2019.02.020","article-title":"Glycogen synthase kinase-3 inhibitor as a multi-targeting anti-rheumatoid drug","volume":"165","author":"Arioka","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114817_bb0105","first-page":"vi28-36","article-title":"Evolution of treatment for rheumatoid arthritis","volume":"51 Suppl 6","author":"Upchurch","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.intimp.2025.114817_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2024.105732","article-title":"Retention of triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine compared to combination methotrexate and leflunomide in rheumatoid arthritis","volume":"91","author":"Bhavsar","year":"2024","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.intimp.2025.114817_bb0115","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/FTD.0b013e31826a6306","article-title":"Old and new antirheumatic drugs and the risk of hepatotoxicity","volume":"34","author":"Anelli","year":"2012","journal-title":"Ther. Drug Monit."},{"issue":"12","key":"10.1016\/j.intimp.2025.114817_bb0120","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2165\/11316650-000000000-00000","article-title":"Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing","volume":"32","author":"Alcorn","year":"2009","journal-title":"Drug Saf."},{"issue":"4","key":"10.1016\/j.intimp.2025.114817_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ph17040431","article-title":"Silibinin\u2019s effects against methotrexate-induced hepatotoxicity in adjuvant-induced arthritis rat model","volume":"17","author":"Khawaja","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.intimp.2025.114817_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118689","article-title":"Hepatoprotective effect of gentiopicroside in combination with leflunomide and\/or methotrexate in arthritic rats","volume":"265","author":"Wan","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2025.114817_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2024.106413","article-title":"Monotropein mitigates methotrexate-induced liver injury by activating autophagy and inhibiting ferroptosis","volume":"121","author":"Du","year":"2024","journal-title":"J. Funct. Foods"},{"issue":"1","key":"10.1016\/j.intimp.2025.114817_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-kappaB: a key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.intimp.2025.114817_bb0145","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/art.11095","article-title":"The JAK\/STAT pathway in rheumatoid arthritis: pathogenic or protective?","volume":"48","author":"Ivashkiv","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.intimp.2025.114817_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41584-020-00541-7","article-title":"Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis","volume":"17","author":"Buch","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114817_bb0155","doi-asserted-by":"crossref","first-page":"653","DOI":"10.5312\/wjo.v5.i5.653","article-title":"Inhibition of rheumatoid arthritis by blocking connective tissue growth factor","volume":"5","author":"Nozawa","year":"2014","journal-title":"World J. Orthop."},{"issue":"12","key":"10.1016\/j.intimp.2025.114817_bb0160","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2016.175","article-title":"Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers","volume":"12","author":"Brown","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114817_bb0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.biocel.2004.06.017","article-title":"MMP-1: the elder of the family","volume":"37","author":"Pardo","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114817_bb0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-2478(02)00079-2","article-title":"Regulation of TNF-alpha-mediated hyperplasia through TNF receptors, TRAFs, and NF-kappaB in synoviocytes obtained from patients with rheumatoid arthritis","volume":"83","author":"Youn","year":"2002","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2025.114817_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114676","article-title":"Fisetin promotes osteoblast differentiation and osteogenesis through GSK-3beta phosphorylation at Ser9 and consequent beta-catenin activation, inhibiting osteoporosis","volume":"192","author":"Molagoda","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2025.114817_bb0180","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/mc.22685","article-title":"Inhibition of glycogen synthase kinase 3 beta (GSK3beta) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity","volume":"56","author":"Gao","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"3","key":"10.1016\/j.intimp.2025.114817_bb0185","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4049\/jimmunol.1003511","article-title":"Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells","volume":"186","author":"Beurel","year":"2011","journal-title":"J. Immunol."},{"issue":"6791","key":"10.1016\/j.intimp.2025.114817_bb0190","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35017574","article-title":"Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation","volume":"406","author":"Hoeflich","year":"2000","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2025.114817_bb0195","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2025.114817_bb0200","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.biopha.2017.05.055","article-title":"Rheumatoid arthritis: recent advances on its etiology, role of cytokines and pharmacotherapy","volume":"92","author":"Alam","year":"2017","journal-title":"Biomed. Pharmacother."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925008070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925008070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:50:15Z","timestamp":1762552215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925008070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":40,"alternative-id":["S1567576925008070"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114817","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monotropein synergizes with methotrexate to attenuate synovial inflammation in adjuvant-induced arthritis mice and fibroblast-like synoviocyte via GSK-3\u03b2","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114817"}}